Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)

China flag China · Delayed Price · Currency is CNY
39.66
-3.88 (-8.91%)
May 20, 2026, 12:24 PM CST
Market Cap8.54B +236.4%
Revenue (ttm)1.42B -3.8%
Net Income127.19M +87.0%
EPS0.63 +85.6%
Shares Out196.11M
PE Ratio69.03
Forward PEn/a
Dividend0.20 (0.48%)
Ex-Dividend DateNov 24, 2025
Volume20,867,591
Average Volume26,919,758
Open41.91
Previous Close43.54
Day's Range39.19 - 43.50
52-Week Range13.59 - 68.80
Beta0.74
RSI67.49
Earnings DateApr 29, 2026

About SHE:002940

Zhejiang AngLiKang Pharmaceutical CO.,LTD., a pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases. The company also offers products in the areas of anti-infection, cardiovascular, urinary system (nephropathy), anesthesia and pain, and anti-androgen. The company was founded in 2001 and is based in Shengzhou, China. [Read more]

Sector Healthcare
Founded 2001
Employees 1,275
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002940
Full Company Profile

Financial Performance

In 2025, SHE:002940's revenue was 1.42 billion, a decrease of -5.84% compared to the previous year's 1.51 billion. Earnings were 125.44 million, an increase of 56.15%.

Financial Statements